Project Details
Description
Vulnerable plaques are prone to rupture and can cause acute coronary
syndromes. The goal of these 3 collaborative projects are to identify
the mechanisms related to the formation and stabilization of vulnerable
plaques and to develop non-invasive methods for their detection and
characterization. This project will characterize vulnerable plaques by
MRI in humans. In aim 1, asymptomatic patients with dyslipidemia and
patients with stroke will be screened for plaques in the thoracic aorta
and carotid arteries. Plasma lipid levels will be modified by therapy
with a statin or statin plus niacin (to raise HDL) and changes in plaque
size and composition will be followed serially by MRI. In aim 2, a
porcine model of human coronary artery disease will be used to develop
MRI techniques to detect and characterize coronary plaques, then these
techniques will be applied to humans. Overall, the projects represent
highly interactive efforts of experienced investigators who will develop
new approaches to the vulnerable plaque using molecular biology, animal
models, clinical investigation, and MRI.
Status | Finished |
---|---|
Effective start/end date | 30/09/98 → 31/08/03 |
Funding
- National Heart, Lung, and Blood Institute: $325,100.00
- National Heart, Lung, and Blood Institute: $650,200.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.